Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Prognostic significance of lymphatic invasion in lymph node-positive breast carcinoma: findings from a large case series with long-term follow-up using immunohistochemical endothelial marker.

Mohammed RA, Menon S, Martin SG, Green AR, Paish EC, Ellis IO.

Mod Pathol. 2014 Dec;27(12):1568-77. doi: 10.1038/modpathol.2014.60. Epub 2014 Apr 25.

2.

Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.

Mohammed RA, Martin SG, Mahmmod AM, Macmillan RD, Green AR, Paish EC, Ellis IO.

J Pathol. 2011 Feb;223(3):358-65. doi: 10.1002/path.2810. Epub 2010 Dec 6.

PMID:
21171081
3.
4.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
5.

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.

Gudlaugsson E, Skaland I, Undersrud E, Janssen EA, Søiland H, Baak JP.

Mod Pathol. 2011 Apr;24(4):502-11. doi: 10.1038/modpathol.2010.199. Epub 2011 Feb 11.

6.

High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.

Zhao H, Yang M, Zhao J, Wang J, Zhang Y, Zhang Q.

Med Oncol. 2013 Mar;30(1):475. doi: 10.1007/s12032-013-0475-1. Epub 2013 Feb 1.

PMID:
23371253
7.

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.

Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN.

Mod Pathol. 2007 Feb;20(2):183-91. Epub 2007 Jan 5.

8.

The prognostic significance of early stage lymph node positivity in operable invasive breast carcinoma: number or stage.

Rakha EA, Morgan D, Macmillan D.

J Clin Pathol. 2012 Jul;65(7):624-30. doi: 10.1136/jclinpath-2012-200755. Epub 2012 Apr 20.

PMID:
22523340
9.

In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival.

Bonin S, Pracella D, Barbazza R, Sulfaro S, Stanta G.

Virchows Arch. 2015 May;466(5):571-80. doi: 10.1007/s00428-015-1748-1. Epub 2015 Feb 28.

PMID:
25724181
10.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

11.

Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.

Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K.

Med Oncol. 2013;30(3):615. doi: 10.1007/s12032-013-0615-7. Epub 2013 Jun 1.

PMID:
23729267
12.

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.

Aleskandarany MA, Rakha EA, Ahmed MA, Powe DG, Paish EC, Macmillan RD, Ellis IO, Green AR.

Breast Cancer Res Treat. 2010 Jul;122(1):45-53. doi: 10.1007/s10549-009-0508-9. Epub 2009 Aug 22.

PMID:
19701705
13.

Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.

Liu F, Cui L, Zhang Y, Chen L, Wang Y, Fan Y, Lei T, Gu F, Lang R, Pringle GA, Zhang X, Chen Z, Fu L.

Breast Cancer Res Treat. 2010 Dec;124(3):677-88. doi: 10.1007/s10549-010-0790-6. Epub 2010 Mar 9.

PMID:
20213083
14.

Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.

Mimae T, Tsutani Y, Miyata Y, Yoshiya T, Ibuki Y, Kushitani K, Takeshima Y, Nakayama H, Okumura S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):1820-6. doi: 10.1016/j.jtcvs.2013.11.050. Epub 2013 Dec 31.

15.

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM.

Cancer. 2003 Feb 1;97(3):545-53.

16.

Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.

Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK.

Am J Clin Oncol. 2009 Aug;32(4):411-6. doi: 10.1097/COC.0b013e31819142dc.

PMID:
19451800
17.

The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.

Khoshnaw SM, Rakha EA, Abdel-Fatah T, Nolan CC, Hodi Z, Macmillan RD, Ellis IO, Green AR.

Breast Cancer Res Treat. 2013 Jan;137(1):139-53. doi: 10.1007/s10549-012-2358-0. Epub 2012 Dec 6.

PMID:
23225145
18.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

19.

Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.

Zhang Y, Yan M, He J, Sun J, Sun X.

J Obstet Gynaecol Res. 2010 Oct;36(5):1015-22. doi: 10.1111/j.1447-0756.2010.01271.x. Epub 2010 Sep 16.

PMID:
20846259
20.

The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.

Lauria R, Perrone F, Carlomagno C, De Laurentiis M, Morabito A, Gallo C, Varriale E, Pettinato G, Panico L, Petrella G, et al.

Cancer. 1995 Nov 15;76(10):1772-8.

Supplemental Content

Support Center